FDA Approves New Treatment For ALS

The FDA announced approval of #Relyvrio, developed by #Amylyx Pharmaceuticals, on Thursday. The oral medication works as a standalone therapy or when added to other treatments, according to the company, and it has been shown to slow disease progression.

Details: https://www.cbsnews.com/boston/news/als-drug-relyvrio-ice-bucket-challenge-funding/?intcid=CNM-00-10abd1h

#cbsnewsmiami #news #health #medical #fda #als